Privacy Policy
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. (hereinafter referred to as "the Company") shall comply with
the Personal Information Protection Law, guidelines regarding the protection of personal
information, and any other related laws and regulations concerning the protection andhandling of personal information that the Company acquires from its business partners suchas enterprises, schools, medical institutions, and public-service corporations. (Thesebusiness partners shall include their executives and employees, and shall be hereinafterreferred to as "the User(s).")
Article 1: Secure Management of Personal Information
With respect to the protection of personal information, the Company shall implement
appropriate organizational, physical, personnel, and technological measures and takenecessary and appropriate countermeasures to prevent leakage, loss, or damage of personal
information handled by the Company, and to otherwise safely manage personal information.
Article 2: Compliance with Acquisition and Usage of Personal Information
Regarding the acquisition, usage, and provision of personal information by the Company, theCompany shall comply with the following paragraphs in Article 2:(1) Collection and Acquisition of Personal Information
For the purposes specified in the paragraph (2) below, the Company may collect personal
information such as name, place of employment, affiliated department, address, telephone
number and email address via paper or electronic media.
Additionally, based on the Users’ prior consent, the Company may obtain personal
information from the Company’s partners including information providers, advertisers, andad distributors (hereinafter referred to as "the Partner(s)") after the Users provide suchinformation to the Partners.
(2) Usage Purpose of Personal Information
With regard to personal information that the Company collects or acquires, the Company
shall not use it beyond the scope necessary to achieve the following purposes, except asotherwise provided by law or with the consent of the Users:① For conducting surveys or collecting information related to the Company's products
and/or services② For notifying the Users of events such as seminars, lectures, information sessions, andstudy sessions organized by the Company

③ For sending information about any products and/or services used by the Users orinformation about any products and/or services provided by the Company or the Partners(including by email or any other electronic means)④ For any necessary notices such as important notifications regarding the proper use of
the Company's products and/or services (including but not limited to in vitro diagnostic
pharmaceuticals, research reagents, antibodies, antigens, and genetically modifiedanimals)⑤ For responding to inquiries from the Users (including implementation of User identityverification)⑥ For identifying the Users who have violated the terms of use or who attempt to use theCompany’s products and/or services for fraudulent or unjust purposes and refusing themto use the products and/or services⑦ For allowing the Users to view, modify, or delete their own registration information, orcheck their usage status⑧ For any other purposes associated with the above usage purposes(3) Provision of Personal Information
Except as otherwise provided by law, the Company shall not provide any personal
information obtained based on the Users’ consent to third parties without prior consent fromthe User.
However, the Company shall respond to the Users’ requests for disclosing, correcting, adding,or deleting personal information or notifying any usage purpose of personal information inaccordance with laws, and handle the User’s opinions and inquiries accordingly.
(4) Personal Information Related to Clinical Trials
Notwithstanding the provisions of the preceding paragraphs, if the Company acquires
personal information when conducting clinical trials for any product development, it shallestablish separate provisions in accordance with, including but not limited to laws,
government ordinances, ministry ordinances, notifications, or guidelines related to clinical
trials.
Article 3: Change of Usage Purpose of Personal Information
In principle, the Company shall not change the usage purposes of personal information
identified in the preceding paragraph, except with the Users’ prior consent. However, thisshall not apply in cases where the Company changes any of the usage purposes byannouncing the changed usage purpose in advance, to the extent that the changed usage
purpose is reasonably considered to be duly related to the original usage purpose.

Article 4: Provision of Personal Information to Third Parties
When the Company entrusts all or part of handling of personal information to a third-party,
the Company shall thoroughly examine the eligibility of the third-party and conduct necessary
and appropriate supervision over the entrusted third-party to ensure the safe managementof such personal information.
Article 5: Improvement and Review of Personal Information Handling
The Company shall conduct inspections regarding the handling, management system, andinitiatives for personal information, and continuously improve and review them.
Article 6: Disposal of Personal Information
When the necessity for personal information has been eliminated in light of the usage
purposes, the Company shall erase or dispose of the personal information in a necessary
and appropriate manner to prevent external leakage or any other risks, to the extent
necessary for the performance of duties.
Article 7: Contact InformationThe Company has established the following contact point for inquiries and complaints
regarding this Privacy Policy or handling of personal information:
Institute of Immunology Co., Ltd.
General Affairs Department (in charge of Personal Information Protection)
8th Floor, Nihonseimei Suidobashi Building, 1-1-10 Koraku, Bunkyo-ku, Tokyo, Japan
Email: privacy@tokumen.co.jp